QA: Lexicon Pharmaceuticals INC in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001062822_2014_Lexicon_Pharmaceuticals_INC.pdf

Logs

Graph

Absolute values for 0001062822, Lexicon Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 134,554,000
1 IntangibleAssetsNetIncludingGoodwill 44,543,000
2 PropertyPlantAndEquipmentNet 41,362,000
3 remainder_Assets 53,701,000
4 LiabilitiesCurrent 19,294,000
5 LiabilitiesNoncurrent 52,553,000
6 remainder_Liabilities 32,150,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,121,000
9 ResearchAndDevelopmentExpense 89,682,000
10 remainder_Expenses -239,000
11 remainder_Revenues 2,222,000
12 remainder_NetIncome 216,000
13 remainder_ComprehensiveNetIncome -21,000
  yvar yval
0 Assets 274,160,000
1 Liabilities 103,997,000
2 Expenses 106,564,000
3 Revenues 2,222,000
4 StockholdersEquity 170,163,000
5 NetIncome -104,126,000
6 ComprehensiveNetIncome -104,136,500
7 BaseVar 243,590,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.41
9 EconomicCapitalRatio 2.61

Edgar->Model Mapping

Feature Distribution

Change over Time